Skip to main content

Table 4 Distribution of the patients (%) with active or inactive Crohn’s disease according to the drugs that were taken before and during the study

From: A snapshot of the nutritional status of Crohn’s disease among adolescents in Brazil: a prospective cross-sectional study

Drug

Before the study

G1

During the study

G1

Active CD

Inactive CD

Active CD

Inactive CD

n (%)

n (%)

n (%)

n (%)

(Group I)

(Group II)

(Group I)

(Group II)

Azathioprine

22(100)

25(86.2)

NS

21(95.4)

18(62.1)

*

Sulfasalazine

3(13.6)

3(10.3)

NS

2(9.1)

1(3.5)

NS

Mesalazine

20(90.9)

15(51.7)

*

10(45.4)

16(55.2)

NS

Ciprofloxacin

12(54.5)

16(55.2)

NS

3(13.6)

12(41)

*

Metronidazole

10(45.4)

11(37.9)

NS

4(18.2)

2(6.9)

NS

Infliximab

8(36.3)

6(20.7)

NS

5(23.1)

5(17.2)

NS

  1. CD Crohn’s disease, G1 group I vs. group II, NS not significant; *p < 0.05